Corvus Pharmaceuticals, Inc. (CRVS) Insider Trading -- Recent Executive & Director Transactions

5 insiders reported 23 Form 4 transactions for Corvus Pharmaceuticals, Inc. (CRVS) over the past 18 months (most recent 2026-05-20). Recent activity: MILLER RICHARD A MD (President and CEO) Buy 1,932 shares, MILLER RICHARD A MD (President and CEO) Buy 5,000 shares, Thompson Peter A. (Director) Buy 15,000 shares, Thompson Peter A. (Director) Buy 30,000 shares, Thompson Peter A. (Director) Buy 15,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-05-20MILLER RICHARD A MDPresident and CEOBuy1,932$23,203
2026-05-20MILLER RICHARD A MDPresident and CEOBuy5,000$60,250
2026-01-30Thompson Peter A.DirectorBuy15,000$37,350
2026-01-30Thompson Peter A.DirectorBuy30,000$450,000
2026-01-30Thompson Peter A.DirectorBuy15,000$145,500
2026-01-30Thompson Peter A.DirectorBuy15,000$187,500
2026-01-30Thompson Peter A.DirectorBuy15,000$54,150
2026-01-30Thompson Peter A.DirectorBuy15,000$30,000
2026-01-30Thompson Peter A.DirectorBuy15,000$49,050
2026-01-30Thompson Peter A.DirectorBuy15,000$41,100
2026-01-30Thompson Peter A.DirectorBuy15,000$39,000
2026-01-30Thompson Peter A.DirectorBuy15,000$14,850
2026-01-30Thompson Peter A.DirectorBuy15,000$14,550
2026-01-30Thompson Peter A.DirectorBuy15,000$24,600
2026-01-30Thompson Peter A.DirectorBuy15,000$31,800
2025-07-01Thompson Peter A.DirectorBuy1.4M$4.9M
2025-07-01Thompson Peter A.DirectorSell1.2M$4.9M
2025-07-01ORBIMED ADVISORS LLCDirectorBuy1.4M$4.9M
2025-07-01OrbiMed Capital GP V LLCDirectorBuy1.4M$4.9M
2025-07-01ORBIMED ADVISORS LLCDirectorSell1.2M$4.9M
2025-07-01OrbiMed Capital GP V LLCDirectorSell1.2M$4.9M
2025-06-06Jones William BentonSee RemarksBuy19,357$67,750
2025-05-09MILLER RICHARD A MDPresident and CEOBuy559,073$2.0M

Source: SEC Form 4 filings · as of 2026-05-20